Free Trial

Equifax (EFX) Competitors

Equifax logo
$226.74 -0.46 (-0.20%)
As of 02:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EFX vs. CCRN, CRAI, FI, G, IQV, IT, OMC, RHI, TRU, and WM

Should you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Fiserv (FI), Genpact (G), IQVIA (IQV), Gartner (IT), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM).

Equifax vs. Its Competitors

Cross Country Healthcare (NASDAQ:CCRN) and Equifax (NYSE:EFX) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.34B0.30-$14.56M-$0.26-47.80
Equifax$5.68B4.94$604.10M$5.1144.37

Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-0.70% 1.72% 1.24%
Equifax 10.95%18.89%7.84%

96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by insiders. Comparatively, 1.4% of Equifax shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cross Country Healthcare currently has a consensus price target of $17.93, suggesting a potential upside of 44.28%. Equifax has a consensus price target of $280.93, suggesting a potential upside of 23.90%. Given Cross Country Healthcare's higher possible upside, equities analysts clearly believe Cross Country Healthcare is more favorable than Equifax.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Equifax
0 Sell rating(s)
8 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Equifax had 25 more articles in the media than Cross Country Healthcare. MarketBeat recorded 29 mentions for Equifax and 4 mentions for Cross Country Healthcare. Equifax's average media sentiment score of 0.82 beat Cross Country Healthcare's score of 0.78 indicating that Equifax is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cross Country Healthcare
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Equifax
11 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cross Country Healthcare has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Comparatively, Equifax has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500.

Summary

Equifax beats Cross Country Healthcare on 15 of the 17 factors compared between the two stocks.

Get Equifax News Delivered to You Automatically

Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EFX vs. The Competition

MetricEquifaxConsulting IndustryBusiness SectorNYSE Exchange
Market Cap$28.04B$6.40B$28.72B$21.69B
Dividend Yield0.87%1.76%2.88%3.59%
P/E Ratio44.3322.1426.0832.38
Price / Sales4.942.73968.6981.13
Price / Cash17.8916.1532.2724.53
Price / Book5.845.267.954.58
Net Income$604.10M$272.15M$196.17M$1.01B
7 Day Performance-1.46%0.00%0.53%1.11%
1 Month Performance-13.60%-4.96%0.36%-0.71%
1 Year Performance-19.11%-12.24%52.22%10.30%

Equifax Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EFX
Equifax
4.9353 of 5 stars
$226.74
-0.2%
$280.93
+23.9%
-21.8%$28.04B$5.68B44.3314,700Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision
CCRN
Cross Country Healthcare
3.7057 of 5 stars
$12.50
+7.9%
$17.93
+43.4%
+3.6%$409.50M$1.34B-48.088,205
CRAI
Charles River Associates
4.2909 of 5 stars
$176.52
-0.2%
$235.00
+33.1%
-5.5%$1.16B$712.91M21.37940
FI
Fiserv
4.8904 of 5 stars
$122.55
-0.1%
$202.73
+65.4%
-40.3%$66.62B$383.42M20.4638,000Trending News
Analyst Downgrade
Analyst Revision
G
Genpact
4.2621 of 5 stars
$39.54
+0.4%
$52.29
+32.2%
-1.5%$6.89B$4.93B13.14140,000
IQV
IQVIA
4.7449 of 5 stars
$203.95
+2.9%
$236.45
+15.9%
-11.6%$34.67B$15.70B29.5288,000
IT
Gartner
4.7554 of 5 stars
$245.46
+2.5%
$356.89
+45.4%
-55.6%$18.59B$6.30B15.1121,044News Coverage
Analyst Forecast
OMC
Omnicom Group
4.7232 of 5 stars
$76.62
+0.2%
$96.29
+25.7%
-26.8%$14.84B$15.91B10.9974,900Positive News
Upcoming Earnings
RHI
Robert Half
4.8876 of 5 stars
$32.12
+2.4%
$45.00
+40.1%
-53.1%$3.27B$5.57B18.3514,700News Coverage
Upcoming Earnings
Analyst Forecast
TRU
TransUnion
4.7667 of 5 stars
$77.75
+0.1%
$108.15
+39.1%
-26.5%$15.14B$4.36B38.8713,400Trending News
Upcoming Earnings
Analyst Revision
WM
Waste Management
4.7667 of 5 stars
$217.17
-0.9%
$254.32
+17.1%
-0.1%$87.48B$22.06B32.2261,700Analyst Forecast

Related Companies and Tools


This page (NYSE:EFX) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners